Under the guidance of Prof. Peter M. Villiger our colleagues from the Department of Rheumatology, Immunology and Allergology have published an interesting, phase 2, randomised, double-blind, placebo-controlled study about the use of Tocilizumab for the treatment of giant cell arteritis in The Lancet. We congratulate the authors to this remarkable achievment!!!


Open Positions

Are you interested in becoming the newest member of the Eggel Lab?


Contact Us

mapUniversity of Bern, Sahlihaus 2
CH-3010 Bern 

map+41 (0)31 632 22 87